All Articles

An alliance of biopharma innovators is set to discuss a critical hurdle in medicine: delivering RNA therapies to tissues beyond the liver, a key to unlocking new treatments.

A new AI tool is scoring thousands of scientific papers, promising to find top research faster and more fairly. But can it truly replace human judgment?

In a strategic move underscoring its American ambitions, UK-based retail powerhouse JD Sports Fashion plc has upgraded its U.S. trading to the OTCQX Best Market, signaling a new chapter in its bid for North American market dominance.

Roundhill doubles down on the AI memory boom with a leveraged ETF. We explore the strategy behind the new RAM fund, its link to the blockbuster DRAM ETF, and the critical risks.

Novartis is betting nearly $2 billion on Antares Therapeutics' novel platform to conquer historically 'undruggable' cancer targets, a move that could redefine oncology.

With a new patent for its AI-powered VVC device, Zero Candida is betting on smart technology to solve a persistent health issue where drugs often fail.

PetVivo's acquisition of PiezoBioMembrane signals a bold leap from animal care to human health, leveraging advanced biomaterials to chase a larger market.

As new EPA rules create a compliance crisis for cities, Calgon Carbon is commercializing a cheaper, greener, custom solution to clean 'forever chemicals'.

How a landmark partnership between Syngenta, McDonald’s, and McCain is using advanced ag-tech to reshape potato farming, empower farmers, and deliver a more sustainable fry.

Best Buy is betting big on RGB LED TVs with exclusive brand partnerships. Is this a true technological leap or a clever retail play? We explore the tech, the strategy, and what it means for your next upgrade.

A new partnership between Novartis and Becoming rentABLE isn't just adding rentals; it's building a new market of trust for travelers with disabilities.

KIND Snacks just hit a major milestone, proving sustainable farming can be a scalable business engine. Here’s how their almond initiative impacts the entire industry.

Ollin Biosciences secured $330M to challenge giants like Roche and Regeneron. Their next-gen antibody shows early promise in treating vision loss.

The Brain Aneurysm Foundation partners with a tech advocacy group to highlight AI's life-saving potential in spotting deadly aneurysms before they rupture.

A startup just raised $5M for a technology that pulls water from the air, even in a desert. It’s a bet on decoupling industrial growth from our planet’s dwindling water supply.

BOTOX® Cosmetic is investing millions in women entrepreneurs. Is it smart philanthropy, or a brilliant new blueprint for brand building and corporate strategy?

Vault's 2026 rankings are out, and the message is clear: Elite boutique banks like Centerview Partners are rewriting the rules for success, prioritizing culture and compensation over pure prestige.

Industrial giant METLEN is diversifying from metals to military hardware, positioning Greece as a key player in Europe's new security architecture.

As data centers and AI push the U.S. grid to its limits, a proven Canadian reactor offers a path to energy security by sidestepping foreign fuel reliance.

Spire Global's latest satellite deployment is more than just hardware heading to orbit. It's a masterclass in vertical integration and a key signal for investors.